Cargando…
Maternal Immunity and Vaccination Influence Disease Severity in Progeny in a Novel Mast Cell-Deficient Mouse Model of Severe Dengue
Sub-neutralizing concentrations of antibodies in dengue infected patients is a major risk factor for the development of dengue hemorrhagic fever and dengue shock syndrome. Here, we describe a mouse model with a deficiency in mast cells (MCs) in addition to a deficiency in Type-I and II IFN receptors...
Autores principales: | Mantri, Chinmay Kumar, Soundarajan, Gayathri, Saron, Wilfried A. A., Rathore, Abhay P. S., Alonso, Sylvie, St. John, Ashley L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152039/ https://www.ncbi.nlm.nih.gov/pubmed/34066286 http://dx.doi.org/10.3390/v13050900 |
Ejemplares similares
-
Japanese encephalitis virus neuropenetrance is driven by mast cell chymase
por: Hsieh, Justin T., et al.
Publicado: (2019) -
Transcriptional Profiling Confirms the Therapeutic Effects of Mast Cell Stabilization in a Dengue Disease Model
por: Morrison, Juliet, et al.
Publicado: (2017) -
Maternal immunity and antibodies to dengue virus promote infection and Zika virus–induced microcephaly in fetuses
por: Rathore, Abhay P. S., et al.
Publicado: (2019) -
Th1-Polarized, Dengue Virus-Activated Human Mast Cells Induce Endothelial Transcriptional Activation and Permeability
por: Syenina, Ayesa, et al.
Publicado: (2020) -
Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19
por: Tan, Janessa Y.J., et al.
Publicado: (2023)